Intended for healthcare professionals

  1. Research
  2. Effects of glucosamine...
  3. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
CCBYNC Open access
Research

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4675 (Published 16 September 2010) Cite this as: BMJ 2010;341:c4675

Data supplement

  • Web Extra

    Extra material supplied by the author

    Files in this Data Supplement:

Related articles

See more

Cited by...

  • Impact of exercise on articular cartilage in people at risk of, or with established, knee osteoarthritis: a systematic review of randomised controlled trials
  • Paracetamol as first line for treatment of knee and hip osteoarthritis
  • Predictors of placebo response to local (intra-articular) therapy in osteoarthritis: an individual patient data meta-analysis protocol
  • Anti-inflammatory properties of natural ingredients used in combinations on adjuvant induced arthritis in rats
  • 2018 update of the EULAR recommendations for the management of hand osteoarthritis
  • Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
  • Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
  • Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis
  • Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA trial bank
  • Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials
  • Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
  • Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
  • Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
  • Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis
  • Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis
  • Diagnosis and management of chronic joint pain in the dog
  • The 2012 ACR guidelines for osteoarthritis: Not a cookbook
  • Interpretation of Metaanalyses: Pitfalls Should Be More Widely Recognized
  • Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study
  • Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
  • Lateral wedge insoles for medial knee osteoarthritis: 12 month randomised controlled trial
  • Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of the knee or hip but results are questionable and likely due to heterogeneity
  • Prescribed regimen is effective
  • Effect size is encouraging
  • Conclusions not supported by methods and results
  • Sticky labels
  • Glucosamine and Chondroitin, for Hip or Knee Osteoarthritis
Back to top